Smith & Nephew (NYSE:SNN) Downgraded to “Buy” Rating by StockNews.com

StockNews.com downgraded shares of Smith & Nephew (NYSE:SNN) from a strong-buy rating to a buy rating in a research note released on Tuesday.

Several other equities analysts have also issued reports on SNN. Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Smith & Nephew Trading Down 0.6 %

NYSE:SNN opened at $24.58 on Tuesday. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The stock’s fifty day moving average price is $29.24 and its two-hundred day moving average price is $27.87. Smith & Nephew has a 52-week low of $23.65 and a 52-week high of $31.72.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Janney Montgomery Scott LLC lifted its stake in Smith & Nephew by 13.8% in the first quarter. Janney Montgomery Scott LLC now owns 9,611 shares of the medical equipment provider’s stock valued at $244,000 after buying an additional 1,165 shares during the period. Headlands Technologies LLC boosted its stake in Smith & Nephew by 225.0% during the 1st quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock worth $98,000 after acquiring an additional 2,666 shares during the last quarter. QRG Capital Management Inc. boosted its stake in Smith & Nephew by 47.0% during the 1st quarter. QRG Capital Management Inc. now owns 93,034 shares of the medical equipment provider’s stock worth $2,359,000 after acquiring an additional 29,754 shares during the last quarter. Bleakley Financial Group LLC grew its holdings in Smith & Nephew by 25.7% during the first quarter. Bleakley Financial Group LLC now owns 14,912 shares of the medical equipment provider’s stock valued at $378,000 after purchasing an additional 3,047 shares during the period. Finally, SageView Advisory Group LLC bought a new stake in Smith & Nephew in the first quarter valued at approximately $249,000. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.